Oalib Open Access Library Journal 2333-9705 2333-9721 Scientific Research Publishing 10.4236/oalib.1112607 Oalib-138199 Articles Biomedical Life Sciences, Business Economics, Chemistry Materials Science, Computer Science Communications, Earth Environmental Sciences, Engineering, Medicine Healthcare, Physics Mathematics, Social Sciences Humanities Exploring the Role of Chemicals and Environmental Factors for Cancer Proliferation Asad Ullah 1 Muhammad Arif 2 Muhammad Waqas 3 Muhammad Hasnain 4 Anam Saira 5 Roha Tariq 6 Faiza Shahzad 7 Hamza Khaliq 7 aSchool of Chemical Engineering, Tianjin University, Tianjin aDepartment of Safety Health and Environmental Engineering, Ming Chi University of Technology, New Taipei aSchool of Biochemistry, Agriculture University, Faisalabad aInstitute of Molecular Aggregation, School of Science, Tianjin University, Tianjin aCollege of Life Science, Northwest Agriculture and Forestry University, Xianyang aDepartment of Biotechnology, Lahore College for Women University, Lahore aCollege of Environment, Hohai University, Nanjing 05 12 2024 11 12 1 19 10, November 2024 17, November 2024 17, December 2024 © Copyright 2014 by authors and Scientific Research Publishing Inc. 2014 This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Cancer is a multifaceted process influenced by a complex relationship of genetic, environmental, and lifestyle factors and remains a major global health concern. This review explores the intricate connections between environmental pollutants, industrial chemicals such as polycyclic aromatic hydrocarbons, benzene, asbestos, dioxins, and cancer, focusing on both their role in the initiation and progression of carcinogenesis and the potential for interventions to mitigate their effects. To understand the underlying mechanisms, the current review article summarized how these environmental factors interact with cellular pathways, including those involved in DNA damage repair, cell cycle regulation, and apoptosis. Key environmental risk factors such as air, radiation, and water pollution, exposure to hazardous industrial chemicals, and lifestyle-related toxins like tobacco are discussed in detail. A holistic strategy that involves reducing exposure to environmental carcinogens and advancing safer chemical therapies may hold the key to breaking the cancer cycle. Subject AreasEnvironmental Sciences and Chemical Engineering Cancer Environmental Carcinogens Chemical Intervention Pollution Control 1. 引言近年来，随着多媒体技术和经济多元全球化的不断发展，跨界思维不断冲击着传统的品牌联合，电商、餐饮、服装等行业相继掀起跨界联合风潮，营销学之父菲利普·科特勒曾经说过：除了主流品牌和小众品牌以外，混合品牌也将在未来占据一席之地，其中这个混合品牌与后面的“跨界品牌联合”在某种程度上是一样的，跨界品牌联合是指处于不同行业边界的品牌跨边界进行合作共同推出新产品 [1] 。在跨界联合的实践过程中有的品牌跨界备受关注，溢出效应明显，例如Rio华为手机结合保时捷设计出的超级旗舰MateRS设计好评如潮，大白兔品牌奶糖与加美净这类日化品牌推出的奶糖味的唇膏，上架即一扫而光，然而有的跨界联合却反响平平，甚至出现负面溢出效果，例如喜茶与杜蕾斯的联合产品没有得到消费者的积极评价，甚至使消费者产生反感情绪。之前关于品牌联合效果影响因素的分析上主要体现在联合匹配性、在产品关系和逻辑上的契合度，以及品牌要素互补性方面，但是在研究跨界联合时没有考虑到跨界品牌双方本身就具有较大的差异性，所以在一定程度上对跨界联合的成败现象并不能完全解释。因此，本文聚焦品牌跨界联合情景下，根据形式与功能的整合程度将品牌跨界联合的整合度分为高、低两种，基于SOR模型 [2] ，进而分析品牌跨界联合时的整合度高低对消费者品牌联合评价的影响机制，并且在这个基础上研究消费者感知价值在品牌跨界联合时的整合度对消费者品牌联合评价的中介作用。 2. 文献回顾及研究假设(一) 品牌跨界联合整合度与消费者品牌联合评价相关研究有关品牌跨界联合的概念大多围绕跨界营销进行，在市场营销中有共生营销的概念，它是指一种合作联盟关系，合作双方及多方为实现资源共享，提升竞争能力而形成的一种长期或者短期联盟合作关系，而品牌跨界联合则是指两个异质行业、互相独立但拥有平等商业地位的品牌通过活化老品牌，共享互补资源，降低成本等方式以推出新产品，从而实现销售额的增加 [3] 。两者具有一定的相似性，因此根据前人的论述及本文的研究内容将品牌跨界联合大致定义为品牌联合的特殊形式，是指同一个新的产品中存有两个来自不同且没有竞争关系行业的品牌。由于合作品牌双方的合作程度对消费者的品牌评价会产生相应的影响，Newmeyer等(2018) [4] 根据联合产品在形式和功能上的结合程度提出了六种整合度不同的品牌联合形式，从低到高依次为同地品牌联合、共同促销、捆绑联合、成分联合、要素联合、共同研发联合，本文根据形式和功能的结合程度，将共同研发联合和元素联合划分为高度整合，成分联合和捆绑联合划分为中度整合，共同促销和同地品牌联合划分为低度整合。一个品牌产品所带来的功能或者形式较为单一，不能满足消费者日益多元的功能需求和价值需求，如果将两个异质性产品进行跨界联合，不仅能够带来冲击固有认知的创新感，还有益于提升消费者的忠诚度，但是差异过大的品牌联合可能会产生负面溢出效应 [5] 。所以大多学者聚焦于品牌跨界联合前的联合匹配性和契合度的研究，忽视了品牌跨界联合过程中的整合程度，而消费者对跨界品牌联合的评价在一定层面上反映出跨界联合双方合作的效果，较高的评价不仅有助于维持对品牌资产较好品牌的忠诚度，还有利于提升品牌资产较弱一方的品牌形象(Lin, 2013)，在跨界品牌联合中合作双方的交融程度越深，即产品整合度越高，越有益于消费者体验到品牌双方各自的优势，感受到跨界联合产品所带来的新奇与价值感，从而促进消费者对跨界品牌联合作出积极评价。综上所述，本文提出假设1：H1：在品牌跨界联合时，产品整合度对品牌联合评价有正向影响。(二) 在品牌跨界联合时，感知价值在产品联合整合度对品牌联合评价中的中介作用消费者感知价值这一概念是基于现代营销中的消费者价值理论，该理论认为营销其实是交换价值与感知价值的过程，消费者在得到产品后会对其付出成本与感知价值效用进行比较，从而给出整体评价 [6] 。消费者感知价值时往往有三个特征，对产品价值会根据自身主观性进行感知，并且倾向于在比较中感知价值，其感知的价值还具有阶梯性 [7] 。因此，范秀成等(2003) [8] 将消费者感知价值概述为消费者对企业提供的产品和服务价值的主观评价，当消费者感知到价值时会对品牌联合产生积极评价，而产品整合度越高，即跨界联合产品无论是形式还是功能方面都高度融合，没有令消费者产生突兀感，能够驱动消费者产生价值感知，将异质的产品进行创新融合，起初的不匹配性能够打破了对原有品牌的刻板印象，再通过后面的高度整合能够使消费者产生创新感知的同时降低跨界创新产品的不确定性，感受到品牌联合带来的综合价值，而消费者的感知价值会影响消费者对品牌的选择，进而促进消费者对品牌联合作出正向评价 [9] 。因此，本文假设在品牌跨界联合过程中，合作双方后期在形式和功能上的产品整合度将影响消费者感知价值，又因为高整合度与品牌联合评价具有正向影响，推测消费者感知价值也将正向影响品牌联合评价。综上所述，本文提出假设2：H2：在品牌跨界联合时，消费者感知价值在产品整合度对消费者品牌联合评价的影响中起到中介作用。基于此，本文以SOR模型为研究框架，将品牌框架联合时的产品整合度作为刺激源，消费者从中获得的价值感知作为个体心理呈现，消费者对品牌联合的评价作为消费者者反应，构建在品牌跨界联合中产品整合程度对品牌联合评价的影响模型，模型如 图1 所示。 <xref ref-type="bibr" rid="oalib.138199-"></xref>Figure 1. Research model图1. 研究模型 图1. 研究模型 3. 实证设计与研究发现1) 研究设计与数据收集这部分由前测和正式实验组成，前测主要是通过了解市场上影响较广的跨界联合产品，并由此确定实验对象，正式实验根据产品组合利用单因素两水平，即产品整合程度高低的组间设计，检验品牌跨界联合时产品整合程度对品牌联合评价的主要影响以及消费者价值感知对其中的中介效应。① 前测。通过网络咨询了解与品牌跨界词条有关的内容，其中包含了有关跨界产品组合功能与形式的324条记录。选择了6组市面上真实的跨界组合案例，分别为蔻驰皮革的贝克家具、加入当尼柔顺剂的汰渍洗衣液、安装劳斯莱斯发动机的空客机、戴尔电脑与佳能打印机、配有迪士尼玩具的儿童餐、出售赛百味三明治的沃尔玛。通过变动产品整合度的操纵方法，让受访者填写整合度的7级量表 [4] ，对这些组合的产品整合度进行打分。此次前测收回有效问卷78份，并通过统计数据分析得出，蔻驰皮革的贝克家具这组共同研发组合的整合度评分均值为M 整合度 = 5.26，出售赛百味三明治的沃尔玛这组同地品牌联合销售的整合度评分均值为M 整合度 = 4.14，两者之间的差异很明显，将蔻驰皮革的贝克家具作为高整合度组合，而将出售赛百味三明治的沃尔玛作为低整合度组合，并将两组组合作为实验的刺激源。② 正式实验。该实验采用单因素两水平的设计，包括了102名消费者，其中人员年龄集中于26~35岁，男性占比42.15%，女性占比57.85%，教育程度占比主要是本科学历，将被试进行随机等量分配，其中高低整合度组各自均为61人。让产品高整合度组的被试浏览蔻驰皮革的贝克家具在功能和形式上的整合材料信息，同时让产品低整合度组的被试浏览沃尔玛出售赛百味三明治的销售整合信息，两组被试在看到品牌跨界联合刺激材料后如实填写产品感知价值量表以及品牌联合评价量表，具体量表题项如 表1 所示。 <xref ref-type="bibr" rid="oalib.138199-"></xref>Table 1. Measurement scaleTable 1. Measurement scale 表1. 测量量表

测量维度

测量题项参考来源

消费者感知价值

讨论/拥有/分享这项联名让我很开心

李慧，周雨(2021)

讨论/拥有/分享这项联名让我给他人留下了好印象

这项联名让我获得了自我满足

Sweeney and Soutar (2001)

该联名是我喜欢的

讨论/拥有/分享这项联名让我结识了很多朋友

品牌联合评价

我认为该产品很吸引人

Shih等(2013)

我非常喜欢该联合产品

该联合产品表达了我的个性
2) 数据分析① 问卷的信效度检验。利用SPSS 24.0对实验中的数据进行信度与效度的检验，其中产品感知价值量表以及品牌联合评价量表的Cronbach’ α系数分别为0.891、0.912，两者均在0.8以上，说明问卷信度较好。同时，通过验证性因子分析得出组合的CR和AVE值，从中发现组合效度AR值大于0.7，说明所选题项的一致性好，AVE值也达到了推荐的标准，所以该变量具有较好的效度。②主效应检验。在品牌跨界联合中，通过独立样本T检验验证产品整合度对消费者品牌联合评价有显著影响，即主效应检验。如 表2 所示，产品整合度不同，消费者对品牌跨界联合评价也显著不同，在产品整合度较高的跨界联合中，消费者对品牌联合评价(M = 2.811)显著高于产品整合度低的跨界联合产品(M = 1.649)，因此本文的假设1得到验证，即在品牌跨界联合时，产品整合度对品牌联合评价有正向影响。 <xref ref-type="bibr" rid="oalib.138199-"></xref>Table 2. Comparison of consumers’ evaluation of co-brand under different product integration degreesTable 2. Comparison of consumers’ evaluation of co-brand under different product integration degrees 表2. 不同产品整合度下消费者对品牌联合评价的差异比较

整合度分组

个案数

平均值

标准差

T值

品牌联合评价

高整合度

61

2.811

0.678

−5.650***

低整合度

61

1.649

0.718
③ 中介效应检验。本文以跨界产品整合度为自变量、消费者感知价值为中介变量、品牌联合评价为因变量，运用PROCESS程序中的model 4，通过Bootstrap方法对感知价值的中介效应进行检验，其中控制性别、年龄等人口特征变量。结果显示，产品整合程度对品牌联合评价的总效应为0.942，95%置信区间为(0.642, 1.193)，直接效应为0.401，95%置信区间为(0.076, 0.723)，均不包括0，产品整合程度对消费者感知价值具有显著的正向影响[B = 1.231, 95%置信区间为(0.844, 1.713), SE = 0.231, t = 5.895, p < 0.01]，消费者感知价值对品牌联合评价具有显著正向影响[B = 0.449, 95%置信区间为(0.289, 0.589), SE = 0.071, t = 6.334, p < 0.01]，从产品整合度到感知价值，再到品牌联合评价，其中的间接效应为0.673，95%的置信区间(0.302, 0.937)，不含0，由此得以验证感知价值在产品整合程度与品牌联合评价关系里起到中介作用。 4. 结论与启示本文通过实证分析研究了处于品牌跨界联合中，产品整合度对品牌联合评价的影响关系，主要得到两个结论：首先，在品牌跨界联合时，相比于产品整合度较低的跨界组合，产品整合度高的跨界组合更能够带来积极的品牌联合评价，即产品整合度对品牌联合评价有正向影响；其次，消费者感知价值在跨界产品整合度对品牌联合评价的影响中起到中介作用。通过实证研究，发现产品整合度越高，越有利于消费者感知价值，同时当消费者感知价值以后会对品牌联合作出积极评价，即消费者感知价值在跨界产品整合度和品牌联合评价中起到中介作用。而SOR理论正是关于刺激对个体心理产生影响，从而产生反应的研究模型，因此本文基于SOR理论，在品牌跨界联合时，产品整合度高这一刺激源使得消费者根据偏好流畅性的心理会降低对跨界创新产品的不确定性，从而增强消费者对该类商品的接受度，并从中感知到联合的综合价值。当消费者感受到情绪价值或者社会价值时会产生积极反应，即较高的品牌联合评价，这不仅维持了消费者对原有品牌产品的忠诚度，又在一定程度上提升了品牌资产，为企业有针对性地进行品牌跨界联合提供了感知价值角度的理论支持。本文的研究为企业进行跨界创新实践活动提供了相应指导。首先，尽管市场上出现的跨界创新现象层出不穷，与不同的品牌进行跨界创新能够在短期内快速吸引消费者，并从长期唤起品牌活力，提升品牌创新能力，但是在这个过程中企业应该结合自身的发展情况和战略模式进行调整，不要跟风进行盲目跨界。合适的跨界能够带来正面效应，但是如果缺少跨界的前提情景和适宜时机，跨界将给企业的发展带来无论是品牌形象还是消费者受众都产生消极影响。其次，在品牌跨界联合时，除了考虑前期匹配性，还需要进行整合度的规划。许多企业在进行品牌联合时往往考虑合作双方固有的形象或者市场是否匹配，匹配性较大可以提升消费者的可接受度，但是也可能固化消费者认知。对于需要进行品牌跨界转型的企业来说，同质品牌联合对于公司的发展战略来说意义不大，如果品牌联合异质性较大，品牌联合发行起初可能会吸引眼球，赚取热度，收获许多受众；对于品牌资产不对等的双方来说，影响也不尽相同，但后期消费者感知的功能和形式方面的异质性过于突出，可能会引起消费者的排斥心理，进而降低消费者评价。企业可以通过提升联合产品在功能和形式方面的交融整合度，产品整合度高时消费者更加容易理解品牌联合的意义和价值，也能够避免品牌联合带来的不适感，降低消费者对冲击固有认知的排斥，进而更加理解品牌融合的真正目的以及给自身带来的价值，有利于提升消费者对品牌联合的认同感，对品牌联合做出积极评价，将不匹配产品转换为一次具有创新意义的匹配产品。最后，如果将跨界产品匹配性作为消费者是否接受的前提条件，那么整合度的提升将有益于消费者从中感受到该跨界联合所带来的综合价值。好的品牌联合除了考虑前期双方的联合匹配度，也要形成良好的产品整合度，如果前期的匹配度不能达到预期，那么可以通过后期从产品和功能方面对匹配联合整合度进行调整，从而激发消费者的购买意愿以及对该品牌联合的积极评价。所以企业在实践中要注意消费者感知价值在产品整合度对品牌联合评价中的中介作用，通过良好的整合促使消费者感知产品价值，进而提升品牌联合评价。 References Ghufran, M.S., Soni, P. and Duddukuri, G.R. (2023) The Global Concern for Cancer Emergence and Its Prevention: A Systematic Unveiling of the Present Scenario. In: Arunachalam, K., Yang, X. and Puthanpura Sasidharan, S., Eds., Bioprospecting of Tropical Medicinal Plants, Springer Nature, 1429-1455. >https://doi.org/10.1007/978-3-031-28780-0_60 Abrams, H.R., Durbin, S., Huang, C.X., Johnson, S.F., Nayak, R.K., Zahner, G.J., et al. (2021) Financial Toxicity in Cancer Care: Origins, Impact, and Solutions. Translational Behavioral Medicine, 11, 2043-2054. >https://doi.org/10.1093/tbm/ibab091 Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T. and Przybyłowicz, K.E. (2021) A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers, 13, Article 2025. >https://doi.org/10.3390/cancers13092025 Wan, M.L.Y., Co, V.A. and El-Nezami, H. (2021) Endocrine Disrupting Chemicals and Breast Cancer: A Systematic Review of Epidemiological Studies. Critical Reviews in Food Science and Nutrition, 62, 6549-6576. >https://doi.org/10.1080/10408398.2021.1903382 Lacouture, A., Lafront, C., Peillex, C., Pelletier, M. and Audet-Walsh, É. (2022) Impacts of Endocrine-Disrupting Chemicals on Prostate Function and Cancer. Environmental Research, 204, Article 112085. >https://doi.org/10.1016/j.envres.2021.112085 Soto, A.M. and Sonnenschein, C. (2021) The Cancer Puzzle: Welcome to Organicism. Progress in Biophysics and Molecular Biology, 165, 114-119. >https://doi.org/10.1016/j.pbiomolbio.2021.07.001 Ahmed, U., Abubakar, M., Ayyoub, R. and Rehman, B. (2024) Stem Cells and Exosomes-Associated Therapeutic Applications. Journal of Clinical and Nursing Research, 8, 232-246. >https://doi.org/10.26689/jcnr.v8i6.7012 Caserta, D., De Marco, M.P., Besharat, A.R. and Costanzi, F. (2022) Endocrine Disruptors and Endometrial Cancer: Molecular Mechanisms of Action and Clinical Implications, a Systematic Review. International Journal of Molecular Sciences, 23, Article 2956. >https://doi.org/10.3390/ijms23062956 Ilic, M. and Ilic, I. (2022) Epidemiology of Stomach Cancer. World Journal of Gastroenterology, 28, 1187-1203. >https://doi.org/10.3748/wjg.v28.i12.1187 Kachuri, L., Chatterjee, N., Hirbo, J., Schaid, D.J., Martin, I., Kullo, I.J., et al. (2023) Principles and Methods for Transferring Polygenic Risk Scores across Global Populations. Nature Reviews Genetics, 25, 8-25. >https://doi.org/10.1038/s41576-023-00637-2 Pourmasoumi, P., Moradi, A. and Bayat, M. (2024) BRCA1/2 Mutations and Breast/Ovarian Cancer Risk: A New Insights Review. Reproductive Sciences, 31, 3624-3634. >https://doi.org/10.1007/s43032-024-01666-w Mallah, M.A., Changxing, L., Mallah, M.A., Noreen, S., Liu, Y., Saeed, M., et al. (2022) Polycyclic Aromatic Hydrocarbon and Its Effects on Human Health: An Overeview. Chemosphere, 296, Article 133948. >https://doi.org/10.1016/j.chemosphere.2022.133948 Dewi, R., Hamid, Z.A., Rajab, N., Shuib, S. and Razak, S.A. (2019) Genetic, Epigenetic, and Lineage-Directed Mechanisms in Benzene-Induced Malignancies and Hematotoxicity Targeting Hematopoietic Stem Cells Niche. Human & Experimental Toxicology, 39, 577-595. >https://doi.org/10.1177/0960327119895570 Mossman, B.T. and Gualtieri, A.F. (2020) Lung Cancer: Mechanisms of Carcinogenesis by Asbestos. In: Anttila, S. and Boffetta, P. Eds., Occupational Cancers, Springer International Publishing, 239-256. >https://doi.org/10.1007/978-3-030-30766-0_12 Jeno, J.G.A., Rathna, R. and Nakkeeran, E. (2021) Biological Implications of Dioxins/Furans Bioaccumulation in Ecosystems. In: Prasad, R., Ed., Environmental and Microbial Biotechnology, Springer, 395-420. >https://doi.org/10.1007/978-981-15-5499-5_14 Vijayraghavan, S. and Saini, N. (2023) Aldehyde-Associated Mutagenesis—Current State of Knowledge. Chemical Research in Toxicology, 36, 983-1001. >https://doi.org/10.1021/acs.chemrestox.3c00045 Diez de los Rios de la Serna, C., Fernández-Ortega, P. and Lluch-Canut, T. (2022) Lifestyle Behavior Interventions for Preventing Cancer in Adults with Inherited Cancer Syndromes: Systematic Review. International Journal of Environmental Research and Public Health, 19, Article 14098. >https://doi.org/10.3390/ijerph192114098 Abubakar, M., Ayyoub, R., Rehman, B., Zubair, M. and Ahmed, U. (2024) Advancing Cancer Stem Cell-Targeted Therapeutic Applications. Proceedings of Anticancer Research, 8, 32-45. >https://doi.org/10.26689/par.v8i5.7043 Salmaninejad, A., Ilkhani, K., Marzban, H., Navashenaq, J.G., Rahimirad, S., Radnia, F., et al. (2021) Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials. Current Pharmaceutical Design, 27, 3161-3169. >https://doi.org/10.2174/1381612827666210426100206 Ahmed, U., Abubakar, M., Khan, S.S. and ur Rehman, B. (2024) Long Non-Coding RNA and Progression of Breast Cancer. Oncology Treatment Discovery, 2, 38-64. >https://doi.org/10.26689/otd.v2i3.7352 Li, Q., Qian, W., Zhang, Y., Hu, L., Chen, S. and Xia, Y. (2023) A New Wave of Innovations within the DNA Damage Response. Signal Transduction and Targeted Therapy, 8, Article No. 338. >https://doi.org/10.1038/s41392-023-01548-8 Verona, F., Pantina, V.D., Modica, C., Lo Iacono, M., D’Accardo, C., Porcelli, G., et al. (2022) Targeting Epigenetic Alterations in Cancer Stem Cells. Frontiers in Molecular Medicine, 2, Article 1011882. >https://doi.org/10.3389/fmmed.2022.1011882 Lee, C., Vo, T.T.T., Wu, C., Chi, M., Lin, C., Fang, M., et al. (2020) The Inducible Role of Ambient Particulate Matter in Cancer Progression via Oxidative Stress-Mediated Reactive Oxygen Species Pathways: A Recent Perception. Cancers, 12, Article 2505. >https://doi.org/10.3390/cancers12092505 Cheng, Z., Wang, Y., Guo, L., Li, J., Zhang, W., Zhang, C., et al. (2022) Ku70 Affects the Frequency of Chromosome Translocation in Human Lymphocytes after Radiation and T-Cell Acute Lymphoblastic Leukemia. Radiation Oncology, 17, Article No. 144. >https://doi.org/10.1186/s13014-022-02113-3 Cani, M., Turco, F., Butticè, S., Vogl, U.M., Buttigliero, C., Novello, S., et al. (2023) How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers? Cancers, 15, Article 2836. >https://doi.org/10.3390/cancers15102836 Barsouk, A., Thandra, K.C., Saginala, K., Rawla, P. and Barsouk, A. (2021) Chemical Risk Factors of Primary Liver Cancer: An Update. Hepatic Medicine: Evidence and Research, 12, 179-188. >https://doi.org/10.2147/hmer.s278070 Romaguera, D., Fernández-Barrés, S., Gracia-Lavedán, E., Vendrell, E., Azpiri, M., Ruiz-Moreno, E., et al. (2021) Consumption of Ultra-Processed Foods and Drinks and Colorectal, Breast, and Prostate Cancer. Clinical Nutrition, 40, 1537-1545. >https://doi.org/10.1016/j.clnu.2021.02.033 Marino, P., Mininni, M., Deiana, G., Marino, G., Divella, R., Bochicchio, I., et al. (2024) Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer. Nutrients, 16, Article 800. >https://doi.org/10.3390/nu16060800 Zelber-Sagi, S., Noureddin, M. and Shibolet, O. (2021) Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations. Cancers, 14, Article 103. >https://doi.org/10.3390/cancers14010103 Virolainen, S.J., VonHandorf, A., Viel, K.C.M.F., Weirauch, M.T. and Kottyan, L.C. (2022) Gene-Environment Interactions and Their Impact on Human Health. Genes & Immunity, 24, 1-11. >https://doi.org/10.1038/s41435-022-00192-6 Li, Q., Lei, Y., Zhang, P., Liu, Y., Lu, Q. and Chang, C. (2024) Future Challenges and Prospects for Personalized Epigenetics. In: Tollefsbol, T., Ed., Personalized Epigenetics, Academic Press, 721-744. >https://doi.org/10.1016/b978-0-443-23802-4.00019-3 Shehata, S.A., Toraih, E.A., Ismail, E.A., Hagras, A.M., Elmorsy, E. and Fawzy, M.S. (2023) Vaping, Environmental Toxicants Exposure, and Lung Cancer Risk. Cancers, 15, Article 4525. >https://doi.org/10.3390/cancers15184525 Gavito-Covarrubias, D., Ramírez-Díaz, I., Guzmán-Linares, J., Limón, I.D., Manuel-Sánchez, D.M., Molina-Herrera, A., et al. (2024) Epigenetic Mechanisms of Particulate Matter Exposure: Air Pollution and Hazards on Human Health. Frontiers in Genetics, 14, Article 1306600. >https://doi.org/10.3389/fgene.2023.1306600 Miguel, V., Lamas, S. and Espinosa-Diez, C. (2020) Role of Non-Coding-RNAs in Response to Environmental Stressors and Consequences on Human Health. Redox Biology, 37, Article 101580. >https://doi.org/10.1016/j.redox.2020.101580 Santibáñez-Andrade, M., Quezada-Maldonado, E.M., Rivera-Pineda, A., Chirino, Y.I., García-Cuellar, C.M. and Sánchez-Pérez, Y. (2023) The Road to Malignant Cell Transformation after Particulate Matter Exposure: From Oxidative Stress to Genotoxicity. International Journal of Molecular Sciences, 24, Article 1782. >https://doi.org/10.3390/ijms24021782 Riaz, S., Rasul, A., Khalil, M.A., Ameen, L., Riaz, K., Khan, S.G., et al. (2023) Cancer and Carcinogens. In: Ali, M.Y., Ed., Cancer Targeting Therapies, CRC Press, 20-40. Ahmad, M., Bangash, S.A., Shah, S.S., Chemingui, H. and Abubakar, M. (2024) Revolutionizing Healthcare in the Metaverse: The Power of Blockchain. In: Nijalingappa, P., Gururaj, T., Goyal, S.B., Shukla, V. and Bruno, A., Eds., Examining the Metaverse in Healthcare: Opportunities, Challenges, and Future Directions, IGI Global, 51-76. >https://doi.org/10.4018/979-8-3693-1515-6.ch003 Marquès, M., Domingo, J.L., Nadal, M. and Schuhmacher, M. (2020) Health Risks for the Population Living near Petrochemical Industrial Complexes. 2. Adverse Health Outcomes Other than Cancer. Science of The Total Environment, 730, Article 139122. >https://doi.org/10.1016/j.scitotenv.2020.139122 Rehman, B., Abubakar, M., Kiani, M.N. and Ayyoub, R. (2024) Analysis of Genetic Alterations in TP53 Gene in Breast Cancer—A Secondary Publication. Proceedings of Anticancer Research, 8, 25-35. >https://doi.org/10.26689/par.v8i3.6720 Denk, D. and Greten, F.R. (2022) Inflammation: The Incubator of the Tumor Microenvironment. Trends in Cancer, 8, 901-914. >https://doi.org/10.1016/j.trecan.2022.07.002 Ali, Y.F., Cucinotta, F.A., Ning-Ang, L. and Zhou, G. (2020) Cancer Risk of Low Dose Ionizing Radiation. Frontiers in Physics, 8, Article 234. >https://doi.org/10.3389/fphy.2020.00234 Abubakar, M., Ayyoub, R., Rehman, B., Kiani, M.N., Ahmed, U., Farooq, J., et al. (2024) Exploring Novel Therapeutic Breakthroughs for Cancers: Potential Roles of miRNAs. Proceedings of Anticancer Research, 8, 11-24. >https://doi.org/10.26689/par.v8i5.6924 Khaliq, H., Shahzad, F., Ullah, A., Abid, M.A. and Gul, H. (2024) A Review on Emerging Contaminants: Effects on Human Health and Cancer Risks. Journal of Clinical and Nursing Research, 8, 57-73. >https://doi.org/10.26689/jcnr.v8i10.5724 Wakeford, R. and Hauptmann, M. (2022) The Risk of Cancer Following High, and Very High, Doses of Ionising Radiation. Journal of Radiological Protection, 42, Article 020518. >https://doi.org/10.1088/1361-6498/ac767b Hussein, H.A., Thabet, A.A., Wardany, A.A. et al. (2024) SARS-CoV-2 Outbreak: Role of Viral Proteins and Genomic Diversity in Virus Infection and COVID-19 Progression. Virology Journal, 21, 75. Lange, K.W. and Nakamura, Y. (2020) Lifestyle Factors in the Prevention of COVID-19. Global Health Journal, 4, 146-152. >https://doi.org/10.1016/j.glohj.2020.11.002 Abubakar, M. (2024) Overview of Skin Cancer and Risk Factors. International Journal of General Practice Nursing, 2, 42-56. >https://doi.org/10.26689/ijgpn.v2i3.8114 Abubakar, M., Khatoon, N. and Saddique, A. (2024) Skin Cancer and Human Papillomavirus. Journal of Population Therapeutics and Clinical Pharmacology, 31, 790-816. Yousaf, A., Tasneem, N., Mustafa, A., Fatima, R., Nabia, N., Khan, R.A., et al. (2021) Gastric Cancer Associated Risk Factors and Prevalence in Pakistan. ASEAN Journal of Science and Engineering, 1, 73-78. >https://doi.org/10.17509/ajse.v1i2.41124 Islami, F., Torre, L.A. and Jemal, A. (2015) Global Trends of Lung Cancer Mortality and Smoking Prevalence. Translational Lung Cancer Research, 4, 327-338. >https://doi.org/10.3978/j.issn.2218-6751.2015.08.04 Näsman, A., Du, J. and Dalianis, T. (2019) A Global Epidemic Increase of an HPV‐Induced Tonsil and Tongue Base Cancer—Potential Benefit from a Pan‐Gender Use of HPV Vaccine. Journal of Internal Medicine, 287, 134-152. >https://doi.org/10.1111/joim.13010 Wang, X., Qian, Z., Zhang, Z., Cai, M., Chen, L., Wu, Y., et al. (2022) Population Attributable Fraction of Lung Cancer Due to Genetic Variants, Modifiable Risk Factors, and Their Interactions: A Nationwide Prospective Cohort Study. Chemosphere, 301, Article 134773. >https://doi.org/10.1016/j.chemosphere.2022.134773 Cho, M. and Cho, Y.H. (2024) Factors Influencing the Intention for Lung Cancer Screening in High-Risk Populations for Lung Cancer. Asia-Pacific Journal of Oncology Nursing, 11, Article 100332. >https://doi.org/10.1016/j.apjon.2023.100332 Hecht, S.S. and Hatsukami, D.K. (2022) Smokeless Tobacco and Cigarette Smoking: Chemical Mechanisms and Cancer Prevention. Nature Reviews Cancer, 22, 143-155. >https://doi.org/10.1038/s41568-021-00423-4 Neuberger, M. (2021) Tobacco and Alternative Nicotine Products and Their Regulation. In: Reichl, F.X. and Schwenk, M., Eds., Regulatory Toxicology, Springer International Publishing, 1127-1151. >https://doi.org/10.1007/978-3-030-57499-4_124 Liang, Y., Kaushal, D. and Wilson, R.B. (2024) Cellular Senescence and Extracellular Vesicles in the Pathogenesis and Treatment of Obesity—A Narrative Review. International Journal of Molecular Sciences, 25, Article 7943. >https://doi.org/10.3390/ijms25147943 Lathigara, D., Kaushal, D. and Wilson, R. (2023) Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis—A Narrative Review. Metabolites, 13, Article 675. >https://doi.org/10.3390/metabo13050675 Rumgay, H., Murphy, N., Ferrari, P. and Soerjomataram, I. (2021) Alcohol and Cancer: Epidemiology and Biological Mechanisms. Nutrients, 13, Article 3173. >https://doi.org/10.3390/nu13093173 Barsouk, A., Aluru, J.S., Rawla, P., Saginala, K. and Barsouk, A. (2023) Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. Medical Sciences, 11, Article 42. >https://doi.org/10.3390/medsci11020042 Han, J., Ye, J., Shi, J., Fan, Y., Yuan, X., Li, R., et al. (2024) A Programmable Oral Nanomotor Microcapsule for the Treatment of Inflammatory Bowel Disease. Advanced Functional Materials. >https://doi.org/10.1002/adfm.202413261 Larsson, S.C., Carter, P., Kar, S., Vithayathil, M., Mason, A.M., Michaëlsson, K., et al. (2020) Smoking, Alcohol Consumption, and Cancer: A Mendelian Randomisation Study in UK Biobank and International Genetic Consortia Participants. PLOS Medicine, 17, e1003178. >https://doi.org/10.1371/journal.pmed.1003178 Abubakar, M. (2024) Exploring the Pivotal Association of AI in Cancer Stem Cells Detection and Treatment. Proceedings of Anticancer Research, 8, 52-63. >https://doi.org/10.26689/par.v8i5.7082 Das, S., Kundu, M., Jena, B.C. and Mandal, M. (2020) Causes of Cancer: Physical, Chemical, Biological Carcinogens, and Viruses. In: Kundu, S.C. and Reis, R.L., Eds., Biomaterials for 3D Tumor Modeling, Elsevier, 607-641. >https://doi.org/10.1016/b978-0-12-818128-7.00025-3 Riaz, M.A., Abubakar, M., Ayyoub, R., Khan, A.N. and Hameed, Y. (2024) Expression Analysis of Caspase-3 (CASP3) Gene in Leukemia Patients Using Quantitative Polymerase Chain Reaction (qPCR) and Western Blot Techniques. Journal of Cancer Biomoleculars and Therapeutics, 1, 10-16. >https://doi.org/10.62382/jcbt.v1i2.17 Ricci, A.M., Emeny, R.T., Bagley, P.J., Blunt, H.B., Butow, M.E., Morgan, A., et al. (2024) Causes of Childhood Cancer: A Review of the Recent Literature: Part I—Childhood Factors. Cancers, 16, Article 1297. >https://doi.org/10.3390/cancers16071297 Abubakar, M. and Rehman, B. (2024) Roles of Mutant TP53 Gene in Cancer Development and Progression. Proceedings of Anticancer Research, 8, 165-181. >https://doi.org/10.26689/par.v8i5.7826 Asefa, E.M., Damtew, Y.T. and Ober, J. (2024) Pesticide Water Pollution, Human Health Risks, and Regulatory Evaluation: A Nationwide Analysis in Ethiopia. Journal of Hazardous Materials, 478, Article 135326. >https://doi.org/10.1016/j.jhazmat.2024.135326 Rakhshaninejad, M., Fathian, M., Shirkoohi, R., Barzinpour, F. and Gandomi, A.H. (2024) Refining Breast Cancer Biomarker Discovery and Drug Targeting through an Advanced Data-Driven Approach. BMC Bioinformatics, 25, Article No. 33. >https://doi.org/10.1186/s12859-024-05657-1 Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y., Luo, Q., et al. (2024) Signaling Pathways Involved in Colorectal Cancer: Pathogenesis and Targeted Therapy. Signal Transduction and Targeted Therapy, 9, Article No. 266. >https://doi.org/10.1038/s41392-024-01953-7 Jansen, S.N.G., Kamphorst, B.A., Mulder, B.C., van Kamp, I., Boekhold, S., van den Hazel, P., et al. (2024) Ethics of Early Detection of Disease Risk Factors: A Scoping Review. BMC Medical Ethics, 25, Article No. 25. >https://doi.org/10.1186/s12910-024-01012-4 Sharma, N., Kumar, V., S., V., Umesh, M., Sharma, P., Thazeem, B., et al. (2024) Hazard Identification of Endocrine-Disrupting Carcinogens (EDCs) in Relation to Cancers in Humans. Environmental Toxicology and Pharmacology, 109, Article 104480. >https://doi.org/10.1016/j.etap.2024.104480 Bellingham, M., Evans, N.P., Lea, R.G., Padmanabhan, V. and Sinclair, K.D. (2024) Reproductive and Metabolic Health Following Exposure to Environmental Chemicals: Mechanistic Insights from Mammalian Models. Annual Review of Animal Biosciences, 13. >https://doi.org/10.1146/annurev-animal-111523-102259 Woodruff, T.J., Rayasam, S.D.G., Axelrad, D.A., Koman, P.D., Chartres, N., Bennett, D.H., et al. (2023) A Science-Based Agenda for Health-Protective Chemical Assessments and Decisions: Overview and Consensus Statement. Environmental Health, 21, Article No. 132. >https://doi.org/10.1186/s12940-022-00930-3